中等强国视角下印度尼西亚的“疫苗公平”外交

Indonesia’s“Vaccine Fairness”Diplomacy from the Perspective of a Middle Power

新冠肺炎疫情暴发后,印度尼西亚佐科政府在国际社会宣扬“疫苗公平”的理念,并以此作为卫生外交的基础。围绕“疫苗公平”,印度尼西亚呼吁国际社会重视疫苗不公平现象,同时加强与中美澳等国的双边合作,开展积极中立的卫生外交,力求在国际社会中塑造“良好国际公民”的中等强国形象。尽管印度尼西亚的卫生外交取得一定的成效,但国家综合实力不足和公共卫生体系建设薄弱制约了卫生外交。这表明,诸如印度尼西亚这一类新兴中等强国,在综合实力与全球治理的维度上存在不匹配现象。因此,观察中等强国在国际舞台上的作用,既要看到中等强国扮演的桥梁角色,也不能忽视其局限性。

After the outbreak of the COVID-19,the Indonesia Jokowi government put forward the concept of“vaccine fairness”in line with its positioning as a middle power,and formed the basis for health diplomacy.With the“vaccine fairness”,Indonesia has promoted relevant concepts in international organizations and called on the international community to pay attention to this issue.At the same time,it strengthens bilateral cooperation with China,the United States,Australia and other countries,and carries out independent health diplomacy.Indonesia’s health diplomacy strives to create a positive image of a middle power in the international community.Although Indonesia’s health diplomacy has achieved certain results,the lack of comprehensive national strength and weak public health construction restrict its diplomatic activities.This also shows that emerging middle powers such as Indonesia have differences in the dimensions of comprehensive strength and global governance.Therefore,the activities of middle powers on the international stage should not only see the bridge role played by such middle powers as Indonesia,but also cannot ignore their own limitations.